All News

The goals are to assess the candidate’s safety and to determine if the vaccination induces the human immune system to produce proteins called neutralizing antibodies.

The National Rosacea Society (NRS) has designated April as Rosacea Awareness month to improve education of rosacea.

The combination therapy reduced the risk of squamous cell carcinoma development on the face and scalp by approximately 75% in the study.

Top news of the week from Specialty Pharmacy Times.

Top news of the day from across the health care industry.

With this approval, certolizumab pegol becomes the first FDA-approved therapy for this type of axSpA, filling an unmet clinical need for treatment options, according to the release.

The action follows discontinuation of quinidine, the only FDA-approved intravenous antimalarial drug in the United States.

Certolizumab pegol (Cimzia) is the first FDA-approved therapy for this type of axial spondyloarthritis, filling an unmet clinical need for treatment options.

Aspirin and heroin were discovered within weeks of each other in 1897 by Felix Hoffmann.

ASHP’s Midyear Clinical Meeting rose 5 spots, from No. 157 to No. 152 out of 250 trade shows with the Consumer Electronics Shows (CES) topping the list.

Overall, more than half of commercially insured individuals who initiated pre-exposure prophylaxis persisted with it for the 12-month duration of the cohort study.

An updated transmission model indicates that most new HIV infections occur due to a lack of diagnosis and treatment.

Top news of the day from across the health care industry.

According to the study, enzyme USP15 may regulate cancer cell response to poly-(ADP-ribose) polymerase inhibitors.

An increasing number of patients with decompensated cirrhosis are receiving direct-acting antiviral treatment and attaining sustained virologic response of hepatitis C, however, their long-term outcomes are unclear.

Officials with the FDA approved Wednesday testosterone undecanoate (Jatenzo, Clarus Therapeutics), an oral testosterone capsule for treating men with certain forms of hypogonadism.

The drug is indicated to for men with low testosterone levels due to specific medical conditions, such as genetic disorders, including Klinefelter syndrome or tumors that have damaged the pituitary gland.

The acquisition of Wellcare Health Plans will create a centralized health care enterprise focused on government-sponsored health care programs on the forefront of Medicaid, Medicare, and the Health Insurance Marketplace for Centene.

Lannett officials said that the company received approval of its Abbreviated New Drug Application (ANDA) for Aspirin and Extended-Release Dipyridamole Capsules, 25 mg/200 mg, a generic version of Aggrenox® Capsules, 25 mg/200 mg (Boehringer Ingelheim Pharmaceuticals).

Novartis’ siponimod (Mayzent) is approved for adults with active secondary progressive multiple sclerosis, clinically isolated syndrome, and relapsing-remitting disease.

Program uses archived samples from patients with known treatment outcomes to accelerate research in predicting therapeutic responses for future patients with cancer.